INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $88,000 | -40.9% | 25,263 | +114.7% | 0.00% | -60.0% |
Q2 2017 | $149,000 | -71.4% | 11,767 | -76.3% | 0.01% | -68.8% |
Q1 2017 | $521,000 | +33.6% | 49,589 | +16.9% | 0.02% | +60.0% |
Q4 2016 | $390,000 | +146.8% | 42,405 | +216.5% | 0.01% | +150.0% |
Q3 2016 | $158,000 | -79.2% | 13,398 | -49.5% | 0.00% | -81.0% |
Q4 2015 | $759,000 | +44.0% | 26,517 | +43.1% | 0.02% | +16.7% |
Q3 2015 | $527,000 | +4.6% | 18,532 | +32.1% | 0.02% | +20.0% |
Q2 2015 | $504,000 | +89.5% | 14,030 | +207.0% | 0.02% | +66.7% |
Q1 2015 | $266,000 | -49.3% | 4,570 | -63.3% | 0.01% | -50.0% |
Q4 2014 | $525,000 | -39.5% | 12,448 | -44.4% | 0.02% | -41.9% |
Q3 2014 | $868,000 | +57.8% | 22,394 | +27.1% | 0.03% | +47.6% |
Q2 2014 | $550,000 | – | 17,626 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
Front Row Advisors LLC | 60 | $0 | 0.00% |
Executive Wealth Management, LLC | 20 | $0 | 0.00% |
BARCLAYS PLC | 1,300 | $0 | 0.00% |
BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
Vectors Research Management, LLC | 505 | $0 | 0.00% |